News Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 23, 2012
Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2011 Financial Results Conference Call BEDFORD, Mass. --(BUSINESS WIRE)--Feb. 23, 2012-- Anika Therapeutics, Inc. (Nasdaq: ANIK)...
-
Feb 2, 2012
Anika Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference on February 7 BEDFORD, Mass. --(BUSINESS WIRE)--Feb. 2, 2012-- Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader in...
-
Jan 10, 2012
Anika Therapeutics to Present at the Eighth Annual Noble Financial Equity Conference on January 17 BEDFORD, Mass. --(BUSINESS WIRE)--Jan. 10, 2012-- Anika Therapeutics, Inc. (Nasdaq: ANIK) a...
-
Dec 21, 2011Anika Therapeutics Announces U.S. MONOVISC® License and Supply Agreement with DePuy Mitek, Inc.
BEDFORD, Mass.--(BUSINESS WIRE)--Dec. 21, 2011-- Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced the signing of an exclusive, multi-year U.S. licensing and supply agreement with DePuy...
-
Nov 30, 2011
BEDFORD, Mass.--(BUSINESS WIRE)--Nov. 30, 2011-- Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”)...
-
Nov 10, 2011
Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today announced that Chief Financial Officer...
-
Nov 2, 2011EARNINGS PER SHARE GROW 144% TO 22¢
BEDFORD, Mass., Nov 02, 2011 (BUSINESS WIRE) -- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair, based on hyaluronic acid ("HA")...
-
Oct 25, 2011
BEDFORD, Mass., Oct 25, 2011 (BUSINESS WIRE) -- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its third-quarter 2011 financial results after the close of the...
-
Sep 6, 2011
BEDFORD, Mass., Sep 06, 2011 (BUSINESS WIRE) -- Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology,...
-
Aug 18, 2011
BEDFORD, Mass., Aug 18, 2011 (BUSINESS WIRE) -- Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced the appointment of Jing-wen Kuo, Ph.D. as chief scientific officer. For the last nine years,...